American biopharmaceutical company Amgen is expanding its presence in India, recognising the country’s potential in life sciences innovation and technology. The company plans to invest $200 ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

Rs 1,600 crore) at the new site during 2025, with plans for additional "significant investments" in future years, Amgen chairman & CEO Robert A Bradway said on Monday. Inaugurating the centre ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

HYDERABAD: US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ... national executive India, Amgen, said the first 300 ...

Amgen chairman and CEO Robert A. Bradway, US Consul General Jennifer Larsen and Amgen India representatives Som Chattopadhyay and Naveen Gullapalli were present at the event.

"The opening of Amgen India marks a significant milestone in our endeavour to leverage technology across our global network to better serve patients,” Robert A. Bradway, CEO of Amgen said.

During a growth-fueled stock market sell-off, investors would typically expect the Dow to hold up a lot better than the S&P ...

CEOs need to understand the arm’s-length rules for transactions between commonly controlled entities because of the enormous ...

Novartis shareholders elected Giovanni Caforio as new member and Chair of the Board of Directors as well as Elizabeth McNally as new member of the Board of Directors. Joerg Reinhardt, Charles L.

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...